$340.65
3.68% yesterday
NYSE, Apr 03, 10:00 pm CET
ISIN
US8243481061
Symbol
SHW

Sherwin-Williams Target price 2025 - Analyst rating & recommendation

Sherwin-Williams Classifications & Recommendation:

Buy
53%
Hold
37%
Sell
10%

Sherwin-Williams Price Target

Target Price $393.62
Price $340.65
Potential 15.55%
Number of Estimates 21
21 Analysts have issued a price target Sherwin-Williams 2026 . The average Sherwin-Williams target price is $393.62. This is 15.55% higher than the current stock price. The highest price target is $430.00 26.23% , the lowest is $300.00 11.93% .
A rating was issued by 30 analysts: 16 Analysts recommend Sherwin-Williams to buy, 11 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sherwin-Williams stock has an average upside potential 2026 of 15.55% . Most analysts recommend the Sherwin-Williams stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028


Dec '24 2025
Estimates
Revenue Billion $ 23.10 23.71
0.20% 2.66%
EBITDA Margin 19.04% 20.05%
3.42% 5.30%
Net Margin 11.48% 12.12%
13.82% 5.59%

23 Analysts have issued a sales forecast Sherwin-Williams 2025 . The average Sherwin-Williams sales estimate is $23.7b . This is 2.66% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $24.1b 4.26% , the lowest is $23.1b 0.05% .

This results in the following potential growth metrics:

Revenue Estimates

2024 $23.1b 0.20%
2025 $23.7b 2.66%
2026 $25.0b 5.23%
2027 $26.5b 6.00%
2028 $27.2b 2.93%

24 Analysts have issued an Sherwin-Williams EBITDA forecast 2025. The average Sherwin-Williams EBITDA estimate is $4.8b . This is 7.96% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.0b 13.75% , the lowest is $4.6b 4.25% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $4.4b 3.63%
2025 $4.8b 8.11%
2026 $5.2b 9.57%
2027 $5.7b 9.45%
2028 $5.7b 0.10%

EBITDA Margin

2024 19.04% 3.42%
2025 20.05% 5.30%
2026 20.88% 4.14%
2027 21.56% 3.26%
2028 20.97% 2.74%

11 Sherwin-Williams Analysts have issued a net profit forecast 2025. The average Sherwin-Williams net profit estimate is $2.9b . This is 8.43% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.1b 15.17% , the lowest is $2.7b 0.95% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $2.7b 14.05%
2025 $2.9b 8.43%
2026 $3.3b 13.39%
2027 $3.7b 13.53%
2028 $3.8b 2.94%

Net Margin

2024 11.48% 13.82%
2025 12.12% 5.59%
2026 13.06% 7.76%
2027 13.99% 7.12%
2028 13.99% 0.00%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028


Dec '24 2025
Estimates
Earnings Per Share $ 10.55 11.44
14.05% 8.44%
P/E 29.78
EV/Sales 4.15

11 Analysts have issued a Sherwin-Williams forecast for earnings per share. The average Sherwin-Williams EPS is $11.44 . This is 8.44% higher than earnings per share in the financial year 2024. The highest EPS forecast is $12.15 15.17% , the lowest is $10.65 0.95% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $10.55 14.05%
2025 $11.44 8.44%
2026 $12.97 13.37%
2027 $14.73 13.57%
2028 $15.16 2.92%

P/E ratio

Current 32.30 14.10%
2025 29.78 7.80%
2026 26.26 11.82%
2027 23.13 11.92%
2028 22.47 2.85%

Based on analysts' sales estimates for 2025, the Sherwin-Williams stock is valued at an EV/Sales of 4.15 and an P/S ratio of 3.61 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.26 1.62%
2025 4.15 2.66%
2026 3.94 4.97%
2027 3.72 5.66%
2028 3.61 2.85%

P/S ratio

Current 3.71 3.12%
2025 3.61 2.60%
2026 3.43 4.97%
2027 3.24 5.66%
2028 3.15 2.85%

Current Sherwin-Williams Upgrades & Downgrades

Analyst Rating Action Date
Wells Fargo
Equal-Weight
Equal-Weight
Unchanged Apr 03 2025
Barclays
Equal-Weight
Equal-Weight
Unchanged Apr 01 2025
Jefferies
Buy
Hold
Downgrade Mar 10 2025
Citigroup
Buy
Unchanged Feb 26 2025
RBC Capital
Outperform
Outperform
Unchanged Feb 03 2025
JP Morgan
Overweight
Overweight
Unchanged Feb 03 2025
Morgan Stanley
Overweight
Overweight
Unchanged Jan 28 2025
Analyst Rating Date
Unchanged
Wells Fargo:
Equal-Weight
Equal-Weight
Apr 03 2025
Unchanged
Barclays:
Equal-Weight
Equal-Weight
Apr 01 2025
Downgrade
Jefferies:
Buy
Hold
Mar 10 2025
Unchanged
Citigroup:
Buy
Feb 26 2025
Unchanged
RBC Capital:
Outperform
Outperform
Feb 03 2025
Unchanged
JP Morgan:
Overweight
Overweight
Feb 03 2025
Unchanged
Morgan Stanley:
Overweight
Overweight
Jan 28 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today